@article{ATM3960,
author = {Paula I. Moreira},
title = {Metformin in the diabetic brain: friend or foe?},
journal = {Annals of Translational Medicine},
volume = {2},
number = {6},
year = {2014},
keywords = {},
abstract = {Diabetes is fast becoming the epidemic of the 21st century. Individuals with type 2 diabetes (T2D) are at an increased risk for developing cognitive disorders, such as Alzheimer disease (AD). To avoid or slow the development of T2Dassociated complications anti-diabetic agents should be capable of achieving the desired glycemic and metabolic control goal, which should be as close to normal as possible.},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/3960}
}